This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Thursday's Small-Cap Winners & Losers

Shares of TVI (TVIN) were sliding 16% after the company said it would have to restate downward its results for the third quarter. TVI, a maker of first-responder systems for medical personnel, police and fire departments, said it will need to eliminate around $550,000, or about 6.1%, of its reported revenue for the quarter.

Restated net income will likely be $973,000, or 3 cents a share, a decrease of $239,000, or 1 cent a share, from the numbers TVI previously reported. TVI was losing 47 cents to $2.43.

Auxilium Pharmaceuticals (AUXL) was dropping after it said it has suspended the dosing of patients taking part in phase III trials for AA4500, an experimental treatment for a condition called Dupuytren's contracture.

The company cited a problem with some of the freeze-dried material that was being used in the trials. Auxilium believes the issue was related to the freeze-drying process itself or the equipment that was used. Dupuytren's contracture is characterized by thickening of the tissues in the palm and fingers. The condition can cause the fingers to curl into the palm. Shares of Auxilium were down 8.7% to $14.57.
2 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
AUXL $36.47 -0.16%
HURC $32.73 0.00%
MFRI $6.74 0.00%
TAGS $28.10 0.00%
AAPL $95.18 0.00%


Chart of I:DJI
DOW 17,750.91 -140.25 -0.78%
S&P 500 2,063.37 -18.06 -0.87%
NASDAQ 4,763.2240 -54.37 -1.13%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs